サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1644217

強度変調放射線治療の世界市場

Intensity Modulated Radiation Therapy

出版日
ページ情報
英文 160 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
強度変調放射線治療の世界市場
出版日: 2025年01月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 160 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

強度変調放射線治療の世界市場は2030年までに35億米ドルに到達

2024年に26億米ドルと推定される強度変調放射線治療の世界市場は、分析期間2024-2030年にCAGR 4.7%で成長し、2030年には35億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである電子線治療は、CAGR 4.7%を記録し、分析期間終了時には13億米ドルに達すると予測されます。炭素イオン放射線療法セグメントの成長率は、分析期間中CAGR 4.0％と推定されます。

米国市場は推定6億9,110万米ドル、中国はCAGR4.7％で成長予測

米国の強度変調放射線治療市場は、2024年に6億9,110万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに5億5,970万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは4.7%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.4%と4.2%と予測されています。欧州では、ドイツがCAGR 4.0%で成長すると予測されています。

世界の強度変調放射線治療市場- 主要動向と促進要因のまとめ

なぜ強度変調放射線治療ががん治療を変革するのか？

強度変調放射線治療（IMRT）は、周囲の健康な組織へのダメージを最小限に抑えながら、腫瘍をターゲットとする比類のない精度を提供し、先進的ながん治療の礎石として登場しました。この革新的な技術は、放射線ビームの強度を調節することにより、高度にコンフォーマルな放射線量の照射を可能にし、複雑で不規則な形状の腫瘍の治療に特に効果的です。がんの罹患率が世界的に上昇を続ける中、IMRTは従来の放射線治療と比較して治療成績を向上させ、副作用を軽減することができるため、腫瘍内科医に好まれる選択肢となりつつあります。IMRTは、頭頸部がん、前立腺がん、脳腫瘍など、重要な臓器の近くに位置するがんの治療に特に有益です。その精度の高さは、合併症を減らし、敏感な部位の機能を維持することで、患者の生活の質を著しく向上させています。さらに、より多くのヘルスケアプロバイダーやがん治療センターがIMRTを治療に取り入れるにつれて、IMRTへのアクセスや採用が拡大しています。患者中心の治療への注目の高まりと、先進的で非侵襲的な治療オプションへの需要の高まりが、先進国市場および新興ヘルスケア市場におけるIMRTの普及を後押ししています。

技術の進歩はIMRTの能力をどのように高めているか？

IMRTの分野では目覚ましい技術進歩が見られ、放射線腫瘍学をリードする治療法としての地位をさらに強固なものにしています。IMRTに画像誘導放射線治療（IGRT）が統合されたことで、腫瘍の動きや患者の位置を考慮したリアルタイムの画像診断が組み込まれ、治療の精度が大幅に向上しました。この組み合わせにより、肺や腹部のようなダイナミックな解剖学的領域であっても、意図したターゲットに正確に放射線を照射することができます。さらに、治療計画ソフトウェアと機械学習アルゴリズムの進歩により、より個別化された適応的な放射線治療が可能になりつつあります。これらの技術革新により、臨床医は個々の患者の特徴、腫瘍生物学、治療に対する反応性に基づいて治療を調整することができます。また、自動治療計画システムの採用により、複雑なIMRTプロトコルの開発に必要な時間が短縮され、腫瘍センターの業務効率が向上しています。さらに、陽子線治療のような新たな技術がIMRTと統合されることで、さらに精度の高い治療が可能になり、小児がんや難治性がんの治療に新たな展望が開かれつつあります。

IMRT採用の主な市場動向は？

IMRTの導入は、大規模な腫瘍センターから小規模な地域病院まで、多様なヘルスケア環境で急速に拡大しています。北米や欧州などの先進地域では、確立されたヘルスケアインフラと有利な償還政策により、IMRTの広範な導入が促進されています。また、これらの地域では、生活習慣に関連したがんの増加や高齢化により、高度な放射線治療技術に対する需要が急増しています。新興市場、特にアジア太平洋地域では、ヘルスケア投資の増加や高度ながん治療オプションに対する意識の高まりにより、IMRTの導入が大幅に増加しています。中国やインドのような国の政府は、この地域で急増するがんの負担に対処するため、IMRTのような最先端技術を備えた専門のがん治療センターの設立を優先しています。さらに、民間のヘルスケアプロバイダーは、最先端のIMRTソリューションを提供する技術ベンダーとの提携を増やし、これらの地域における腫瘍治療の質を高めています。

IMRT市場の成長を促進する要因とは？

IMRT市場の成長は、世界のがん罹患率の増加、精密医療に対する需要の高まり、放射線治療技術の進歩など、いくつかの要因によってもたらされます。治療に関連する合併症を減らし、生存率を向上させるIMRTの利点に対する認識の高まりは、市場成長の主要な促進要因です。さらに、先進的ながん治療へのアクセスを改善することを目的とした政府の支援政策や資金援助イニシアティブが、市場の拡大に大きな役割を果たしています。エンドユースの動向も市場を形成しており、病院、がん治療センター、放射線腫瘍専門クリニックがIMRTの主な導入先となっています。外来がん治療への嗜好の高まりが、小型で費用対効果の高いIMRTシステムの需要をさらに押し上げています。一方、遠隔医療と遠隔治療計画の進歩により、十分な治療を受けられない地域でもIMRTを広く利用できるようになり、がん治療における地理的格差に対処できるようになっています。これらの要因を総合すると、がん治療に革命をもたらし、世界中の患者とヘルスケアプロバイダーの進化するニーズに応えるIMRTの戦略的重要性が強調されます。

セグメント

放射線タイプ（電子放射線、炭素イオン放射線、光子放射線、陽子放射線）、アプリケーション（乳がんアプリケーション、前立腺がんアプリケーション、婦人科がんアプリケーション、肺がんアプリケーション、脳腫瘍アプリケーション、その他のアプリケーション）

調査対象企業の例（注目の52社）

  • Accuray, Inc.
  • Brainlab AG
  • Elekta AB
  • IBA Dosimetry GmbH
  • Mevion Medical Systems, Inc.
  • Panacea Medical Technologies Pvt. Ltd.
  • Protom International
  • RAYSEARCH Laboratories AB
  • Reflexion Medical, Inc.
  • Siemens Healthineers AG

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP31654

Global Intensity Modulated Radiation Therapy Market to Reach US$3.5 Billion by 2030

The global market for Intensity Modulated Radiation Therapy estimated at US$2.6 Billion in the year 2024, is expected to reach US$3.5 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Electron Radiation Therapy, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Carbon-Ion Radiation Therapy segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$691.1 Million While China is Forecast to Grow at 4.7% CAGR

The Intensity Modulated Radiation Therapy market in the U.S. is estimated at US$691.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$559.7 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Intensity Modulated Radiation Therapy Market - Key Trends & Drivers Summarized

Why Is Intensity Modulated Radiation Therapy Transforming Cancer Treatment?

Intensity Modulated Radiation Therapy (IMRT) has emerged as a cornerstone in advanced cancer treatment, offering unparalleled precision in targeting tumors while minimizing damage to surrounding healthy tissues. This innovative technology allows for the delivery of highly conformal radiation doses by modulating the intensity of radiation beams, making it particularly effective in treating complex and irregularly shaped tumors. As cancer prevalence continues to rise globally, IMRT is becoming a preferred choice for oncologists due to its ability to improve treatment outcomes and reduce side effects compared to traditional radiation therapies. IMRT is especially beneficial in treating cancers located near critical organs, such as head and neck cancers, prostate cancer, and brain tumors. Its precision has significantly enhanced the quality of life for patients by reducing complications and preserving functionality in sensitive areas. Furthermore, as more healthcare providers and cancer treatment centers integrate IMRT into their offerings, its accessibility and adoption have expanded. The growing focus on patient-centric care and the increasing demand for advanced, non-invasive treatment options are driving the widespread adoption of IMRT across developed and emerging healthcare markets.

How Are Technological Advancements Enhancing IMRT’s Capabilities?

The field of IMRT has witnessed remarkable technological advancements, further cementing its position as a leading modality in radiation oncology. The integration of image-guided radiation therapy (IGRT) with IMRT has significantly improved the accuracy of treatment delivery by incorporating real-time imaging to account for tumor movement and patient positioning. This combination ensures that radiation is delivered precisely to the intended target, even in dynamic anatomical regions such as the lungs and abdomen. Additionally, advancements in treatment planning software and machine learning algorithms are enabling more personalized and adaptive radiation therapy. These innovations allow clinicians to tailor treatments based on individual patient characteristics, tumor biology, and response to therapy. The adoption of automated treatment planning systems is also reducing the time required to develop complex IMRT protocols, enhancing operational efficiency in oncology centers. Furthermore, emerging technologies such as proton therapy are being integrated with IMRT to provide even greater precision, opening new frontiers in the treatment of pediatric and hard-to-treat cancers.

What Are the Key Market Trends in the Adoption of IMRT?

The adoption of IMRT is growing rapidly across diverse healthcare settings, from large oncology centers to smaller community hospitals. In developed regions such as North America and Europe, well-established healthcare infrastructures and favorable reimbursement policies have facilitated the widespread implementation of IMRT. These regions are also witnessing a surge in demand for advanced radiation therapy technologies due to the increasing prevalence of lifestyle-related cancers and aging populations. Emerging markets, particularly in Asia-Pacific, are experiencing a significant uptick in IMRT adoption due to rising healthcare investments and growing awareness of advanced cancer treatment options. Governments in countries like China and India are prioritizing the establishment of specialized cancer treatment centers equipped with state-of-the-art technologies like IMRT to address the region’s burgeoning cancer burden. Moreover, private healthcare providers are increasingly partnering with technology vendors to offer cutting-edge IMRT solutions, enhancing the quality of oncology care in these regions.

What Factors Are Driving the Growth of the IMRT Market?

The growth in the Intensity Modulated Radiation Therapy market is driven by several factors, including the increasing global burden of cancer, the rising demand for precision medicine, and advancements in radiation therapy technologies. The growing awareness of the benefits of IMRT in reducing treatment-related complications and improving survival rates is a key driver of market growth. Additionally, supportive government policies and funding initiatives aimed at improving access to advanced cancer treatments are playing a significant role in the market’s expansion. End-use trends are also shaping the market, with hospitals, cancer treatment centers, and specialized radiation oncology clinics being the primary adopters of IMRT. The growing preference for outpatient cancer care has further boosted demand for compact and cost-effective IMRT systems. Meanwhile, advancements in telemedicine and remote treatment planning are enabling wider access to IMRT in underserved areas, addressing geographical disparities in cancer care. Collectively, these factors underscore the strategic importance of IMRT in revolutionizing cancer treatment and meeting the evolving needs of patients and healthcare providers worldwide.

SCOPE OF STUDY:

The report analyzes the Intensity Modulated Radiation Therapy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Radiation Type (Electron Radiation, Carbon-Ion Radiation, Photon Radiation, Proton Radiation); Application (Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application, Brain Cancer Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 52 Featured) -

  • Accuray, Inc.
  • Brainlab AG
  • Elekta AB
  • IBA Dosimetry GmbH
  • Mevion Medical Systems, Inc.
  • Panacea Medical Technologies Pvt. Ltd.
  • Protom International
  • RAYSEARCH Laboratories AB
  • Reflexion Medical, Inc.
  • Siemens Healthineers AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Intensity Modulated Radiation Therapy - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cancer Fuels Demand for Intensity Modulated Radiation Therapy (IMRT)
    • Advancements in Imaging Technologies Propel Innovation in IMRT Techniques
    • Focus on Precision and Reduced Side Effects Drives Adoption of IMRT
    • Integration with AI and Machine Learning Enhances Treatment Planning in IMRT
    • Increasing Use of IMRT in Pediatric Oncology Expands Applications
    • Focus on Real-Time Tumor Monitoring Strengthens Demand for Adaptive IMRT Solutions
    • Rising Awareness of Patient-Centric Care Drives Growth in Personalized IMRT Treatments
    • Advancements in Linear Accelerator Technologies Boost Efficiency of IMRT Systems
    • Growth in Radiation Therapy Centers Expands Accessibility to IMRT Treatments
    • Focus on Cost-Effective Treatment Options Drives Development of Scalable IMRT Solutions
    • Integration with Proton Therapy Systems Creates New Opportunities for IMRT
    • Rising Adoption of Cloud-Based Platforms Enhances Data-Driven IMRT Planning
    • Emergence of AI-Driven Quality Assurance Systems Improves Accuracy in IMRT Delivery
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intensity Modulated Radiation Therapy Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Intensity Modulated Radiation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Electron Radiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Electron Radiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Carbon-Ion Radiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Carbon-Ion Radiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Photon Radiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Photon Radiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Proton Radiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Proton Radiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Breast Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Breast Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Prostate Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Prostate Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Gynecological Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Gynecological Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Lung Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Lung Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Brain Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Brain Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 24: USA Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • JAPAN
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • CHINA
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 36: China Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: China 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • EUROPE
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 41: Europe 6-Year Perspective for Intensity Modulated Radiation Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Europe 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • FRANCE
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 46: France Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: France 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 48: France Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: France 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • GERMANY
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 50: Germany Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Germany 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 52: Germany Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Germany 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • ITALY
    • TABLE 54: Italy Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Italy 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 56: Italy Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Italy 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • UNITED KINGDOM
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 58: UK Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: UK 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 60: UK Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: UK 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 62: Rest of Europe Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Rest of Europe 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 64: Rest of Europe Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Rest of Europe 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 66: Asia-Pacific Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Asia-Pacific 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 68: Asia-Pacific Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Asia-Pacific 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 70: Rest of World Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Rest of World 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 72: Rest of World Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Rest of World 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030

IV. COMPETITION